Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling

Documenti analoghi

• Enzyme‐responsive 612‐AYR nanoparticles for targeted inhibition of B4GALT3‐mediated ITGB1 glycosylation in hepatocellular carcinoma
  di: Xiaohui Yu, et al.
  Pubblicazione: (2026)
• Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects
  di: Louise M. Hesketh, et al.
  Pubblicazione: (2026)
• Beyond TGFβ inhibition: Chitosan oligosaccharide targets PGC‐1α‐mediated mitochondrial repair to combat pulmonary fibrosis
  di: Huan He, et al.
  Pubblicazione: (2025)
• Population pharmacokinetics and bioavailability of tacrolimus oral suspension in children with haematopoietic stem cell transplant
  di: Lucas Brstilo, et al.
  Pubblicazione: (2025)
• Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis
  di: Xia'nan Sang, et al.
  Pubblicazione: (2026)